The value of modern mammography screening in the control of breast cancer: Understanding the underpinnings of the current debates

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 7, 2014, Pages 1139-1146

  Smith, Robert A ^a  

^a AMERICAN CANCER SOCIETY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; BREAST CANCER; CANCER CONTROL; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CLINICAL EFFECTIVENESS; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FOLLOW UP; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; INCIDENCE; INTENTION TO TREAT ANALYSIS; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; META ANALYSIS (TOPIC); MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR;

EID: 84904010168     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0946     Document Type: Review

References (64)

1. Shapiro S, Strax P, Venet L. Periodic breast cancer screening in reducing mortality from breast cancer. JAMA 1971;215: 1777-5.
2. Miller AB. Early detection and mass screening for cancer. Can Fam Physician 1972;18: 76-9.
3. Morgan RW, Vakil DV. Etiology of breast cancer. III. Opportunities for prevention. Can Med Assoc J 1974;111: 1105-7.
4. Bailar JC 3rd. Mammography: a contrary view. Ann Intern Med 1976; 84: 77-84.
5. Baker LH. Breast Cancer Detection Demonstration Project: five-year summary report. CA Cancer J Clin 1982;32: 194-5.
6. Tabar L, Fagerberg CJ, Gad A, Baldetorp L, Holmberg LH, Grontoft O, et al. Reduction in mortality from breast cancer after mass screening withmammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985;1: 829-2.
7. Wald N, Chamberlain J, Hackshaw A. Report of the European Society of Mastology Breast Cancer Screening Evaluation Committee. Tumori 1993;79: 371-9.
8. Breast-cancer screening with mammography in women aged 40-9 years. Swedish Cancer Society and the Swedish National Board of Health and Welfare. Int J Cancer 1996;68: 693-9.
9. Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S. Report of the international workshop on screening for breast cancer. J Natl Cancer Inst 1993;85: 1644-6.
10. National Institutes of Health Consensus Development Panel. National Institutes of Health Consensus Development Conference Statement: Breast Cancer Screening for Women Ages 40-9, January 21-3, 1997. National Institutes of Health Consensus Development Panel. J Natl Cancer Inst 1997;89: 1015-6.
11. Olsen O, Gotzsche PC. Screening for breast cancer with mammography (Cochrane Review). Cochrane Database Syst Rev 2001;4: CD001877.
12. Leitch AM, Dodd GD, Costanza M, Linver M, Pressman P, McGinnis L, et al. American Cancer Society guidelines for the early detection of breast cancer: update 1997. CA Cancer J Clin 1997;47: 150-3.
13. U.S. Preventive Services Task Force. Screening for breast cancer: recommendations and rationale. Ann Intern Med 2002;137: 344-6.
14. Schousboe JT, Kerlikowske K, Loh A, Cummings SR. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med 2011;155: 10-0.
15. Mandelblatt JS, Stout N, Trentham-Dietz A. To screen or not to screen women in their 40s for breast cancer: is personalized risk-based screening the answer? Ann Intern Med 2011;155: 58-60.
16. Tabar L, Chen HH, Fagerberg G, Duffy SW, Smith TC. Recent results from the Swedish Two-County Trial: the effects of age, histologic type, and mode of detection on the efficacy of breast cancer screening. J Natl Cancer Inst Monogr 1997;22: 43-7.
17. Hendrick RE, Smith RA, Rutledge JH 3rd, Smart CR. Benefit of screening mammography in women aged 40-9: a new metaanalysis of randomized controlled trials. J Natl Cancer Inst Monogr 1997;22: 87-92.
18. Andersson I, Janzon L. Reduced breast cancer mortality in women under age 50: updated results from the Malmo Mammographic Screening Program. J Natl Cancer Inst Monogr 1997;22: 63-7.
19. Bjurstam N, Bjorneld L, Duffy SW, Smith TC, Cahlin E, Eriksson O, et al. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-9 years at randomization. Cancer 1997;80: 2091-9.
20. Salzmann P, Kerlikowske K, Phillips K. Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age. Ann Intern Med 1997;127: 955-65. Erratum in Ann Intern Med 1998;128: 878
21. Berry DA. Benefits and risks of screening mammography for women in their forties: a statistical appraisal. J Natl Cancer Inst 1998;90: 1431-9.
22. US Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009;151: 716-6.
23. Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Koning HJ, Draisma G, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med 2009;151: 738-7.
24. Harris R, Sawaya GF, Moyer VA, Calonge N. Reconsidering the criteria for evaluating proposed screening programs: reflections from 4 current and former members of the U.S. Preventive services task force. Epidemiol Rev 2011;33: 20-5.
25. Broeders M, Moss S, Nystrom L, Njor S, Jonsson H, Paap E, et al. The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen 2012;19 Suppl 1: 14-5.
26. Gotzsche PC, Jorgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2013;6: CD001877.
27. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet 2012;380: 1778-86.
28. Duffy SW, Chen TH, Smith RA, Yen AM, Tabar L. Real and artificial controversies in breast cancer screening: a perspective article. Breast Cancer Manage 2013;2: 519-8.
29. Puliti D, Duffey SW, Miccinesi G, de Koning H, Lynge E, Zappa M, et al. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen 2012;19: 42-6.
30. Autier P, Boniol M, Gavin A, Vatten LJ. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis ofWHOmortality database. BMJ 2011;343: d4411.
31. Esserman L, Shieh Y, Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA 2009;302: 1685-92.
32. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012;367: 1998-005.
33. Zahl PH, Gotzsche PC, Maehlen J. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study. Lancet Oncol 2011;12: 1118-4.
34. Baum M. Should routine screening by mammography be replaced by a more selective service of risk assessment/risk management? Womens Health (Lond Engl) 2010;6: 71-6.
35. Welch HG. Screening mammography-A long run for a short slide? N Engl J Med 2010;363: 1276-8.
36. IARC Working Group on the Evaluation of Cancer-Preventive Strategies. Breast cancer screening. Lyon, France: IARC Press; 2002.
37. Smith RA, Saslow D, Sawyer KA, Burke W, Costanza ME, EvansWPIII, et al. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 2003;53: 141-69.
38. American College of Obstetricians-Gynecologists. Practice bulletin no. 122: breast cancer screening. Obstet Gynecol 2011;118: 372-82.
39. Tabar L, Vitak B, Tony HH, Yen MF, Duffy SW, Smith RA. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 2001;91: 1724-1.
40. Paci E, Duffy SW, Giorgi D, Zappa M, Crocetti E, Vezzosi V, et al. Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme 1990-96. Br J Cancer 2002;87: 65-9.
41. Olsen AH, Njor SH, Vejborg I, Schwartz W, Dalgaard P, Jensen MB, et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ 2005;330: 220.
42. Coldman A, Phillips N, Warren L, Kan L. Breast cancer mortality after screening mammography in British Columbia women. Int J Cancer 2007;120: 1076-80.
43. Duffy SW, Tabar L, Olsen AH, Vitak B, Allgood PC, Chen TH, et al. Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen 2010;17: 25-0.
44. Otto SJ, Fracheboud J, Looman CW, Broeders MJ, Boer R, Hendriks JH, et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 2003;361: 1411-7.
45. Euroscreen Working Group. Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet. J Med Screen 2012;19 Suppl 1: 5-3.
46. Paci E, Broeders M, Hofvind S, Puliti D, Duffey S, Euroscreen Working Group. European breast cancer service screening outcomes: a first balance sheet of the benefits and harms. Cancer Epidemiol Biomarkers Prev 2014;23: 1159-63.
47. Olsen O, Gotzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001;358: 1340-2.
48. de Koning HJ. Assessment of nationwide cancer-screening programmes. Lancet 2000;355: 80-1.
49. Health Council of the Netherlands. The benefit of population screening for breast cancer with mammography. Hague, the Netherlands: Health Council of the Netherlands; 2002. Report No.: 2002/03E.
50. Freedman DA, Petitti DB, Robins JM. On the efficacy of screening for breast cancer. Int J Epidemiol 2004;33: 43-5.
51. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137: 347-60.
52. Nelson HD, Fu R, Griffin JC, Nygren P, Smith ME, Humphrey L. Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer. Ann Intern Med 2009;151: 703-5, W-6-5.
53. Bewley S. The NHS breast screening programme needs independent review. BMJ 2011;343: d6894.
54. Hackshaw A. The benefits and harms of mammographic screening for breast cancer: building the evidence base using service screening programmes. J Med Screen 2012;19 Suppl 1: 1-2.
55. Zappa M, Federici A. The potential for systematic early detection and treatment of breast cancer to reduce the burden of disease is widely recognized in the European Union (EU). Introduction. J Med Screen 2012;19 Suppl 1: 3-4.
56. Moss SM, Nystrom L, Jonsson H, Paci E, Lynge E, Njor S, et al. The impact of mammographic screening on breast cancer mortality in Europe: a review of trend studies. J Med Screen 2012;19 Suppl 1: 26-2.
57. Njor S, Nystrom L, Moss S, Paci E, Broeders M, Segnan N, et al. Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies. J Med Screen 2012; 19: 33-1.
58. Hofvind S, Ponti A, Patnick J, Ascunce N, Njor S, Broeders M, et al. False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes. J Med Screen 2012;19 Suppl 1: 57-66.
59. Puliti D, Miccinesi G, Zappa M, Manneschi G, Crocetti E, Paci E. Balancing harms and benefits of service mammography screening programs: a cohort study. Breast Cancer Res 2012;14: R9.
60. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2009;151: 727-7, W237-2.
61. Tabar L, Vitak B, Chen TH, Yen AM, Cohen A, Tot T, et al. Swedish twocounty trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 2011;260: 658-63.
62. Smith RA, Duffy SW, Gabe R, Tabar L, Yen AM, Chen TH. The randomized trials of breast cancer screening: what have we learned? Radiol Clin North Am 2004;42: 793-806, v.
63. Swedish Organized Service Screening Evaluation Group. Effect of mammographic service screening on stage at presentation of breast cancers in Sweden. Cancer 2007;109: 2205-2.
64. Duffy SW, Tabar L, Chen HH, Holmqvist M, Yen MF, Abdsalah S, et al. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer 2002;95: 458-69.